Literature DB >> 31622142

Increasing Influenza and Pneumococcal Vaccination Uptake in Seniors Using Point-of-Care Informational Interventions in Primary Care in Singapore: A Pragmatic, Cluster-Randomized Crossover Trial.

Hanley J Ho1, Yi-Roe Tan1, Alex R Cook1, Gerald Koh1, Tat Yean Tham1, Eve Anwar1, Grace Shu Hui Chiang1, May O Lwin1, Mark I Chen1.   

Abstract

Objectives. To evaluate the effectiveness of point-of-care informational interventions in general practitioner clinics to improve influenza and pneumococcal vaccination uptake among elderly patients.Methods. We conducted a pragmatic, cluster-randomized crossover trial in 22 private general practitioner clinics in Singapore, from November 2017 to July 2018. We included all patients aged 65 years or older. Clinics were assigned to a 3-month intervention (flyers and posters encouraging vaccination) plus 1-month washout period, and a 4-month control period (usual care). Primary outcomes were differences in vaccination uptake rates between periods. Secondary outcomes were identification of other factors associated with vaccination uptake.Results. A total of 4378 and 4459 patients were included in the intervention and control periods, respectively. Both influenza (5.9% vs 4.8%; P = .047) and pneumococcal (5.7% vs 3.7%; P = .001) vaccination uptake rates were higher during the intervention period compared with the control period. On multilevel logistic regression analysis, follow-up for hypertension, diabetes mellitus, hyperlipidemia, or any combination of the 3 was associated with uptake of both vaccines.Conclusions. Point-of-care informational interventions likely contributed to increased influenza and pneumococcal vaccination uptake. Patients on follow-up for hypertension, diabetes mellitus, hyperlipidemia, or any combination of the 3 were more likely to receive influenza and pneumococcal vaccination and should be actively engaged by physicians.Trial Registration. ClinicalTrials.gov Identifier: NCT03445117.

Entities:  

Year:  2019        PMID: 31622142      PMCID: PMC6836784          DOI: 10.2105/AJPH.2019.305328

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  33 in total

1.  Vaccines against influenza WHO position paper – November 2012.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2012-11-23

2.  Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults.

Authors:  Marc J M Bonten; Susanne M Huijts; Marieke Bolkenbaas; Chris Webber; Scott Patterson; Samantha Gault; Cornelis H van Werkhoven; Anna M M van Deursen; Elisabeth A M Sanders; Theo J M Verheij; Michael Patton; Anne McDonough; Anita Moradoghli-Haftvani; Helen Smith; Tracey Mellelieu; Michael W Pride; Graham Crowther; Beate Schmoele-Thoma; Daniel A Scott; Kathrin U Jansen; Rita Lobatto; Bas Oosterman; Nils Visser; Esther Caspers; Andre Smorenburg; Emilio A Emini; William C Gruber; Diederick E Grobbee
Journal:  N Engl J Med       Date:  2015-03-19       Impact factor: 91.245

3.  Duration of Influenza Vaccine Effectiveness: A Systematic Review, Meta-analysis, and Meta-regression of Test-Negative Design Case-Control Studies.

Authors:  Barnaby Young; Sapna Sadarangani; Lili Jiang; Annelies Wilder-Smith; Mark I-Cheng Chen
Journal:  J Infect Dis       Date:  2018-02-14       Impact factor: 5.226

4.  A formative research-guided educational intervention to improve the knowledge and attitudes of seniors towards influenza and pneumococcal vaccinations.

Authors:  Hanley J Ho; Yin Ying Chan; Muhamad Alif Bin Ibrahim; Anurupa A Wagle; Christina M Wong; Angela Chow
Journal:  Vaccine       Date:  2017-10-12       Impact factor: 3.641

Review 5.  Challenges in adult vaccination.

Authors:  Eduardo de Gomensoro; Giuseppe Del Giudice; T Mark Doherty
Journal:  Ann Med       Date:  2018-01-16       Impact factor: 4.709

6.  Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged ≥65 years: recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors:  Sara Tomczyk; Nancy M Bennett; Charles Stoecker; Ryan Gierke; Matthew R Moore; Cynthia G Whitney; Stephen Hadler; Tamara Pilishvili
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2014-09-19       Impact factor: 17.586

Review 7.  Effectiveness of the 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) against Pneumococcal Disease in the Elderly: Systematic Review and Meta-Analysis.

Authors:  Gerhard Falkenhorst; Cornelius Remschmidt; Thomas Harder; Eva Hummers-Pradier; Ole Wichmann; Christian Bogdan
Journal:  PLoS One       Date:  2017-01-06       Impact factor: 3.240

8.  Coverage and Influencing Determinants of Influenza Vaccination in Elderly Patients in a Country with a Poor Vaccination Implementation.

Authors:  Maria Ganczak; Karolina Gil; Marcin Korzeń; Marta Bażydło
Journal:  Int J Environ Res Public Health       Date:  2017-06-20       Impact factor: 3.390

9.  Influenza-associated deaths in tropical Singapore.

Authors:  Angela Chow; Stefan Ma; Ai Ee Ling; Suok Kai Chew
Journal:  Emerg Infect Dis       Date:  2006-01       Impact factor: 6.883

Review 10.  Vaccines for preventing influenza in the elderly.

Authors:  Vittorio Demicheli; Tom Jefferson; Carlo Di Pietrantonj; Eliana Ferroni; Sarah Thorning; Roger E Thomas; Alessandro Rivetti
Journal:  Cochrane Database Syst Rev       Date:  2018-02-01
View more
  9 in total

1.  An Independent Study to Compare Compliance, Attitudes, Knowledge, and Sources of Knowledge about Pneumococcal Vaccinations among an Italian Sample of Older Adults.

Authors:  Caterina Suitner; Bruno Gabriel Salvador Casara; Stefania Maggi; Vincenzo Baldo
Journal:  Vaccines (Basel)       Date:  2022-03-23

2.  Impact of video-led educational intervention on uptake of influenza vaccine among the elderly in western China: a community-based randomized controlled trial.

Authors:  Minghuan Jiang; Xuelin Yao; Pengchao Li; Yu Fang; Liuxin Feng; Khezar Hayat; Xinke Shi; Yilin Gong; Jin Peng; Naveel Atif
Journal:  BMC Public Health       Date:  2022-06-06       Impact factor: 4.135

3.  Evaluation of multi-component interventions for prevention of nosocomial pneumonia in older adults: a randomized, controlled trial.

Authors:  Barbara H Rosario; Humaira Shafi; Anthony C A Yii; Louis Y Tee; Arron S H Ang; Gek Kheng Png; Wendy S T Ang; Yan Qing Lee; Pei Ting Tan; Aniruddha Sahu; Lin Fang Zhou; Yi Ling Zheng; Roslinda Binte Slamat; Aza A M Taha
Journal:  Eur Geriatr Med       Date:  2021-06-03       Impact factor: 1.710

4.  Seasonal influenza vaccination in older people: A systematic review and meta-analysis of the determining factors.

Authors:  George N Okoli; Otto L T Lam; Florentin Racovitan; Viraj K Reddy; Christiaan H Righolt; Christine Neilson; Ayman Chit; Edward Thommes; Ahmed M Abou-Setta; Salaheddin M Mahmud
Journal:  PLoS One       Date:  2020-06-18       Impact factor: 3.240

Review 5.  What Do Influenza and COVID-19 Represent for Patients With Inflammatory Bowel Disease?

Authors:  Sandra Maria Barbalho; Julia Novaes Matias; Uri Adrian Prync Flato; Joao Paulo Galletti Pilon; Piero Bitelli; Marcos Alberto Pagani Junior; Antonelly Cassio Alves de Carvalho; Jesselina Francisco Dos Santos Haber; Carlos Henrique Bertoni Reis; Ricardo de Alvares Goulart
Journal:  Gastroenterology Res       Date:  2021-02-19

6.  Education, Healthy Ageing and Vaccine Literacy.

Authors:  J-P Michel; J Goldberg
Journal:  J Nutr Health Aging       Date:  2021       Impact factor: 4.075

7.  Uptake of pneumococcal vaccination in older people in northern Israel.

Authors:  Sophia Eilat-Tsanani; Ayelet Vashitz-Giwnewer
Journal:  Prev Med Rep       Date:  2021-09-08

8.  Acceptance Rate of Influenza Vaccination Among Patients with Type II Diabetes.

Authors:  Shahad Ali Alsufyani
Journal:  J Family Med Prim Care       Date:  2022-01-31

9.  A rapid global review of strategies to improve influenza vaccination uptake in Australia.

Authors:  Hassen Mohammed; Mark McMillan; Prabha H Andraweera; Salenna R Elliott; Helen S Marshall
Journal:  Hum Vaccin Immunother       Date:  2021-10-08       Impact factor: 3.452

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.